Enveric Biosciences regains Nasdaq bid price compliance

Enveric Biosciences, Inc.

Received notice from Nasdaq on March 4, 2025 that it complied with Listing Rule 5550(a)(2).
Compliance resolves potential delisting risk due to low stock price.
Company's common stock continues trading on Nasdaq under symbol ENVB.

item 8.01

Enveric Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-009336

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.